| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer HW Cheung, GS Cowley, BA Weir, JS Boehm, S Rusin, JA Scott, A East, ... Proceedings of the National Academy of Sciences 108 (30), 12372-12377, 2011 | 500 | 2011 |
| Cancer vulnerabilities unveiled by genomic loss D Nijhawan, TI Zack, Y Ren, MR Strickland, R Lamothe, SE Schumacher, ... Cell 150 (4), 842-854, 2012 | 244 | 2012 |
| Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 Y Ren, HW Cheung, G Von Maltzhan, A Agrawal, GS Cowley, BA Weir, ... Science translational medicine 4 (147), 147ra112-147ra112, 2012 | 201 | 2012 |
| In Vivo Tumor Cell Targeting with “Click” Nanoparticles G Von Maltzahn, Y Ren, JH Park, DH Min, VR Kotamraju, J Jayakumar, ... Bioconjugate chemistry 19 (8), 1570-1578, 2008 | 193 | 2008 |
| Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells MS Goldberg, D Xing, Y Ren, S Orsulic, SN Bhatia, PA Sharp Proceedings of the National Academy of Sciences 108 (2), 745-750, 2011 | 118 | 2011 |
| Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells MS Goldberg, D Xing, Y Ren, S Orsulic, SN Bhatia, PA Sharp Proceedings of the National Academy of Sciences 108 (2), 745-750, 2011 | 118 | 2011 |
| Silicon nanoparticles as hyperpolarized magnetic resonance imaging agents JW Aptekar, MC Cassidy, AC Johnson, RA Barton, M Lee, AC Ogier, C Vo, ... ACS nano 3 (12), 4003-4008, 2009 | 113 | 2009 |
| Identification and characterization of receptor-specific peptides for siRNA delivery Y Ren, S Hauert, JH Lo, SN Bhatia Acs Nano 6 (10), 8620-8631, 2012 | 81 | 2012 |
| Gene therapy for human sensorineural hearing loss Y Ren, LD Landegger, KM Stankovic Frontiers in Cellular Neuroscience 13, 323, 2019 | 63 | 2019 |
| Acute otitis media and associated complications in United States emergency departments Y Ren, RKV Sethi, KM Stankovic Otology & Neurotology 39 (8), 1005-1011, 2018 | 47 | 2018 |
| Proteome of normal human perilymph and perilymph from people with disabling vertigo HC Lin, Y Ren, AC Lysaght, SY Kao, KM Stankovic PLoS One 14 (6), e0218292, 2019 | 38 | 2019 |
| New developments in neurofibromatosis type 2 and vestibular schwannoma Y Ren, DA Chari, S Vasilijic, DB Welling, KM Stankovic Neuro-Oncology Advances 3 (1), vdaa153, 2021 | 36 | 2021 |
| Targeted delivery of nucleic acids Y Ren, SN Bhatia US Patent 9,006,415, 2015 | 32 | 2015 |
| Targeted delivery of nucleic acids Y Ren, SN Bhatia US Patent 9,006,415, 2015 | 32 | 2015 |
| The role of tumor necrosis factor alpha (TNFα) in hearing loss and vestibular schwannomas Y Ren, KM Stankovic Current otorhinolaryngology reports 6, 15-23, 2018 | 24 | 2018 |
| The presence of Hürthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates Y Ren, N Kyriazidis, WC Faquin, S Soylu, D Kamani, R Saade, N Torchia, ... Thyroid 30 (3), 425-431, 2020 | 22 | 2020 |
| Clinical predictors of facial nerve outcomes after surgical resection of vestibular schwannoma Y Ren, BV MacDonald, KO Tawfik, MS Schwartz, RA Friedman Otolaryngology–Head and Neck Surgery 164 (5), 1085-1093, 2021 | 21 | 2021 |
| Revision neural monitored surgery for recurrent thyroid cancer: Safety and thyroglobulin response B Salari, Y Ren, D Kamani, GW Randolph The Laryngoscope 126 (4), 1020-1025, 2016 | 20 | 2016 |
| MMP-14 (MT1-MMP) is a biomarker of surgical outcome and a potential mediator of hearing loss in patients with vestibular schwannomas Y Ren, H Hyakusoku, JE Sagers, LD Landegger, DB Welling, ... Frontiers in cellular neuroscience 14, 191, 2020 | 18 | 2020 |
| Tumor-penetrating delivery of siRNA against TNFα to human vestibular schwannomas Y Ren, JE Sagers, LD Landegger, SN Bhatia, KM Stankovic Scientific Reports 7 (1), 12922, 2017 | 18 | 2017 |
